Identification of genes involved in epithelial-mesenchymal transition and tumor progression
The DOI matches its Crossref record; 76 of the 76 references it cites were found in a registry or an index.
Abstract
The adenovirus E1A12S gene product (WT12S) immortalizes epithelial cells and they retain their differentiated characteristics, but certain mutants cannot do the latter. Characterization of mutant immortalized epithelial cells indicated that they had undergone epithelial mesenchymal transition (EMT). Coexpression of V12ras with WT12S leads to benign tumors, but to malignant tumors with 12S mutants. Since EMT is critical for tumor progression, identification of the molecular mechanisms involved should elucidate novel therapeutic targets. To this end, representational difference analysis (RDA) was used to identify cDNAs upregulated in the mutant cell line. Thirty-five differentially expressed mRNAs were identified and classified into several functional categories, including nine novel cDNAs. Among the 26 known cDNAs, extracellular matrix and related proteins made up the largest group of differentially expressed genes, followed by growth factors and receptors and transcription factors. There was also an ion transporter, a cytoskeletal protein, glycosylation and amidinotransferase enzymes and proteins with unknown functions. Some of the known genes have previously been associated with EMT and/or tumor progression and thus served to validate the system to obtain the desired target genes, while other cDNAs are newly linked with dedifferentiation/malignancy. Array analyses indicated that the cDNAs were specifically upregulated in invasive or metastatic tumors, especially of breast, uterus and lung, suggesting their involvement in the progression of these tumors.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Moreover, proteins in the most significantly up-regulated network module (Extended Data Fig. 10d, 10f) included collagens (COL1A1 and COL3A1) and extracellular matrix glycoproteins (FN1, BGN, FBN1, and FBN2) that also are markers of EMT34, 35.”
From Proteogenomic characterization of human colon and rectal cancer (2014) · cites this paper as [34]
Citations
Cites
A genetic model for colorectal tumorigenesis
Fearon, E. R., & Vogelstein, B. (1990) · Cell · doi:10.1016/0092-8674(90)90186-i · Cited by 12,132 · cited 1×
“Carcinogenesis is the multistep process of conversion of a normal epithelial cell into one that can proliferate inde®nitely, invade, migrate and metastasize and requires many cellular changes (Fearon and Vogelstein, 1990).”
BackgroundHundahl, S. A., Fleming, I. D., Fremgen, A. M., & Menck, H. R. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19981215)83:12<2638::aid-cncr31>3.0.co;2-1 · Cited by 1,836
An Overview of Epithelio-Mesenchymal Transformation
Hay, E. D. (1995) · Cells Tissues Organs · doi:10.1159/000147748 · Cited by 1,567 · cited 2×
“Such transitions also occur in other pathological situations such as wound healing, but signi®cantly, EMT and MET, its converse process, are normal developmental processes (Hay, 1995).”
BackgroundForm and function: The laminin family of heterotrimers
Colognato, H., & Yurchenco, P. D. (2000) · Developmental Dynamics · doi:10.1002/(sici)1097-0177(200006)218:2<213::aid-dvdy1>3.0.co;2-r · Cited by 1,244
Identification and characterization of a fibroblast marker: FSP1.
Strutz, F., Okada, H., Lo, C. W., Danoff, T., Carone, R. L., Tomaszewski, J. E., & Neilson, E. G. (1995) · The Journal of cell biology · doi:10.1083/jcb.130.2.393 · Cited by 1,077 · cited 1×
“A low level of the mesenchymal marker FSP1 (®broblast speci®c protein 1), which has been implicated in EMT (Strutz et al., 1995; Okada et al., 1997), could be detected.”
BackgroundIdentifying differences in mRNA expression by representational difference analysis of cDNA
Hubank, M., & Schatz, D. G. (1994) · Nucleic Acids Research · doi:10.1093/nar/22.25.5640 · Cited by 883 · cited 2×
“To enrich for genes expressed or upregulated in the HBdl12 population, PCR-representational di erence analysis were performed according to (Hubank and Schatz, 1994) by hybridizing cDNA from the wild type (WT) cells as driver (D) with that from the HBdl 12 mutant cells as tester (T), in a 100:1…”
MethodGlycoprotein glycosylation and cancer progression
Dennis, J. (1999) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/s0304-4165(99)00167-1 · Cited by 652 · cited 1×
“GlcNAc transferases play critical roles in mammalian morphogenesis and some promote tumor growth and metastasis (reviewed in Dennis et al., 1999).”
BackgroundLysyl oxidase: Properties, regulation and multiple functions in biology
Smith-Mungo, L. I., & Kagan, H. M. (1998) · Matrix Biology · doi:10.1016/s0945-053x(98)90012-9 · Cited by 578 · cited 1×
“LOX is an enzyme closely associated with the ECM since it is involved in the cross-linking of collagen and elastin (Smith-Mungo and Kagan, 1998).”
BackgroundInduction and regulation of epithelial–mesenchymal transitions
Boyer, B., Vallés, A. M., & Edme, N. (2000) · Biochemical Pharmacology · doi:10.1016/s0006-2952(00)00427-5 · Cited by 436 · cited 1×
“Thus, tumor progression towards the malignant phenotype requires the loss of the epithelial phenotype and the acquisition of a ®broblastic or mesenchymal one, a reprogramming known as an epithelial-mesenchymal transition (EMT) (reviewed in Birchmeier et al., 1996; Hay, 1995; Boyer et al., 2000).”
BackgroundEarly role of Fsp1 in epithelial-mesenchymal transformation
Okada, H., Danoff, T. M., Kalluri, R., & Neilson, E. G. (1997) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1997.273.4.f563 · Cited by 434 · cited 1×
“A low level of the mesenchymal marker FSP1 (®broblast speci®c protein 1), which has been implicated in EMT (Strutz et al., 1995; Okada et al., 1997), could be detected.”
Background
Cited by
Epithelial–mesenchymal transitions in tumour progression
Thiery, J. P. (2002) · Nature Reviews Cancer · doi:10.1038/nrc822 · Cited by 6,628
The Versatile Role of microRNA-30a in Human Cancer
Wang, C., Yang, X., Chen, Y., & Chen, L. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000471111 · Cited by 3,409
Epithelial-mesenchymal transition and its implications for fibrosis
Kalluri, R., & Neilson, E. G. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200320530 · Cited by 2,649
Proteogenomic characterization of human colon and rectal cancer
CPTAC, T. N., Zhang, B., Wang, J., Wang, X., Zhu, J., Liu, Q., Shi, Z., Chambers, M. C., Zimmerman, L. J., Shaddox, K. F., et al. (2014) · Nature · doi:10.1038/nature13438 · Cited by 1,462
EMT: When epithelial cells decide to become mesenchymal-like cells
Kalluri, R. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39675 · Cited by 952
Transitions between epithelial and mesenchymal states in development and disease
Baum, B., Settleman, J., & Quinlan, M. P. (2008) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2008.02.001 · Cited by 398
Self-citationWent, P., Vasei, M., Bubendorf, L., Terracciano, L., Tornillo, L., Riede, U., Kononen, J., Simon, R., Sauter, G., & Baeuerle, P. A. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6602924 · Cited by 387
A molecular role for lysyl oxidase in breast cancer invasion.
Kirschmann, D. A., Seftor, E. A., Fong, S. F. T., Nieva, D. R. C., Sullivan, C. M., Edwards, E. M., Sommer, P., Csiszar, K., & Hendrix, M. J. C. (2002) · PubMed · Cited by 338
Pavlyukov, M. S., Yu, H., Bastola, S., Minata, M., Shender, V. O., Lee, Y., Zhang, S., Wang, J., Komarova, S., Wang, J., et al. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.05.012 · Cited by 320
“Molecular mechanisms of MES transition in GBM remain unclear; however, multiple studies describe mechanisms of epithelial-to-mesenchymal transition (EMT), a process that is frequently observed in non-brain epithelial cancers and might be analogous to PN-to-MES transition in GBM (Kiemer et al., 2001).”
BackgroundAdenovirus-5 E1A: paradox and paradigm
Frisch, S. M., & Mymryk, J. S. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm827 · Cited by 308
Gotzmann, J., Mikula, M., Eger, A., Schulte-Hermann, R., Foisner, R., Beug, H., & Mikulits, W. (2004) · Mutation Research/Reviews in Mutation Research · doi:10.1016/s1383-5742(03)00033-4 · Cited by 305
Expression profiling of epithelial plasticity in tumor progression
Jechlinger, M., Grunert, S., Tamir, I. H., Janda, E., Lüdemann, S., Waerner, T., Seither, P., Weith, A., Beug, H., & Kraut, N. (2003) · Oncogene · doi:10.1038/sj.onc.1206887 · Cited by 294
“Importantly, only a limited number of the genes associated with EMT in our study were also revealed in respective studies by others (Perou et al., 1999, 2000; Ross et al., 2000; Kiemer et al., 2001; Zavadil et al., 2001; van‘t Veer et al., 2002).”
BackgroundResultBattula, V. L., Evans, K. W., Hollier, B. G., Shi, Y., Marini, F. C., Ayyanan, A., Wang, R.-Y., Brisken, C., Guerra, R., Andreeff, M., et al. (2010) · Stem Cells · doi:10.1002/stem.467 · Cited by 266
Paradoxical roles for lysyl oxidases in cancer—A prospect
Payne, S. L., Hendrix, M. J. C., & Kirschmann, D. A. (2007) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21371 · Cited by 231
Lysyl Oxidase–Like 2 as a New Poor Prognosis Marker of Squamous Cell Carcinomas
Peinado, H., Moreno-Bueno, G., Hardisson, D., Pérez-Gómez, E., Santos, V., Mendiola, M., de Diego, J. I., Nistal, M., Quintanilla, M., Portillo, F., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6345 · Cited by 205
Zhang, J., Guo, H., Zhang, H., Wang, H., Qian, G., Fan, X., Hoffman, A. R., Hu, J., & Ge, S. (2011) · Cancer · doi:10.1002/cncr.25522 · Cited by 181
“previously uncharacterized family of transcription factors and is strongly induced in invasive or metastatic tumor cells.(34) FLI1 is overexpressed in virally induced leukemias and in Ewing sarcoma as a result of a characteristic t(11;22)(q24:q12) reciprocal chromosomal translocation.”
BackgroundYan, W., & Shao, R. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m601856200 · Cited by 169
Daniel, R., Daniels, E., He, Z., & Bateman, A. (2003) · Developmental Dynamics · doi:10.1002/dvdy.10341 · Cited by 154
“Progranulin expression is moderately elevated during epithelial–mesenchyme transition (Kiemer et al., 2001), a process of importance in both embryonic development and tumor progression.”
BackgroundSmith, L. T., Lin, M.-T., Brena, R. M., Lang, J. C., Schuller, D. E., Otterson, G. A., Morrison, C. D., Smiraglia, D. J., & Plass, C. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510171102 · Cited by 169
Schlötzer-Schrehardt, U. M., Pasutto, F., Sommer, P., Hornstra, I. K., Kruse, F. E., Naumann, G. O. H., Reis, A., & Zenkel, M. (2008) · American Journal Of Pathology · doi:10.2353/ajpath.2008.080535 · Cited by 139
Ong, C., & Bateman, A. (2003) · PubMed · doi:10.14670/hh-18.1275 · Cited by 138
GD3 synthase regulates epithelial–mesenchymal transition and metastasis in breast cancer
Sarkar, T. R., Battula, V. L., Werden, S. J., Vijay, G. V., Ramirez‐Peña, E., Taube, J. H., Chang, J. T., Miura, N., Porter, W. W., Sphyris, N., et al. (2014) · Oncogene · doi:10.1038/onc.2014.245 · Cited by 121
An In Vivo Model of Wound Healing in Genetically Modified Skin-Humanized Mice
Escamez, M. J., García, M., Larcher, F., Meana, Á., Muñoz, E., Jorcano, J. L., & Río, M. D. (2004) · Journal of Investigative Dermatology · doi:10.1111/j.0022-202x.2004.23473.x · Cited by 123
“…expression of vimentin in basal keratinocytes occurs, indicating an epithelial–mesenchymal transition, a phenomenon that correlates with the acquisition of an active cell migratory phenotype (Steinert and Roop, 1988; Gibbins et al, 1999; Gilles et al, 1999; Boyer et al, 2000; Kiemer et al, 2001).”
BackgroundFong, S. F. T., Dietzsch, E., Fong, K. S. K., Hollósi, P., Asuncion, L., He, Q., Parker, M. I., & Csiszár, K. (2007) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20444 · Cited by 116
“Moreover, LOXL2 was found to be up-regulated in epithelial to mesenchymal transition, which involves the loss of the epithelial phenotype and gain of a mesenchymal, motile phenotype (Kiemer et al., 2001).”
BackgroundHaraguchi, M., Okubo, T., Miyashita, Y., Miyamoto, Y., Hayashi, M., Crotti, T. N., McHugh, K. P., & Ozawa, M. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m801125200 · Cited by 105
Hayashi, K., Fong, K. S. K., Mercier, F., Boyd, C. D., Csiszár, K., & Hayashi, M. (2004) · The Histochemical Journal · doi:10.1007/s10735-004-2340-1 · Cited by 101
“LOXL was also shown to be upregulated in differentiated kidney epithelial cells undergoing epithelial-mesenchymal transition, suggesting that it may have a role in remodeling the extracellular environment during dynamic processes such as tissue injury, cancer, or development (Kiemer et al. 2001).”
CaNdt80 Is Involved in Drug Resistance in Candida albicans by Regulating CDR1
Chen, C.-G., Yang, Y.-L., Shih, H.-I., Su, C.-L., & Lo, H.-J. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.12.4505-4512.2004 · Cited by 94
“Interestingly, C11orf9, a human transcription factor with a DNA binding domain similar to that of the novel DNA binding motif CaNdt80, is also highly expressed in invasive or metastatic tumor cells (10).”
BackgroundCharacterizing cancer cells with cancer stem cell-like features in 293T human embryonic kidney cells
Debeb, B. G., Zhang, X., Krishnamurthy, S., Gao, H., Cohen, E. N., Li, L., Rodriguez, A. A., Landis, M. D., Lucci, A., Ueno, N. T., et al. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-180 · Cited by 95
Hollósi, P., Yakushiji, J. K., Fong, K. S. K., Csiszár, K., & Fong, S. F. T. (2009) · International Journal of Cancer · doi:10.1002/ijc.24308 · Cited by 91
“The MCF-10A LOXL2 clones did not form ‘‘cobblestone’’ clusters typical of epithelial cells, but acquired a more elongated, spindle-like morphology, a possible response towards EMT.”
BackgroundInfluentialKe, X.-S., Qu, Y., Goldfinger, N., Rostad, K., Hovland, R., Akslen, L. A., Rotter, V., Øyan, A. M., & Kalland, K.-H. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003368 · Cited by 71
“The progeny EPT1 cells exhibited a distinct morphology and increased migration and invasion compared with the parental EP156T cells, and gene expression analysis revealed a striking number of gene expression changes previously found as markers of EMT [2,9,10,23,24].”
BackgroundBillottet, C., Tuefferd, M., Gentien, D., Rapinat, A., Thiery, J., Broët, P., & Jouanneau, J. (2008) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21667 · Cited by 64
“The 35 differentially expressed genes reported for the mutated E1A immortalized cells coded for growth factors, their cognate receptor tyrosine kinases, transcription factors and extracellular matrix proteins [Kiemer et al., 2001].”
BackgroundSatoh (2009) · International Journal of Oncology · doi:10.3892/ijo_00000394 · Cited by 62
Bone morphogenetic protein 3B silencing in non-small-cell lung cancer
Dai, Z., Popkie, A. P., Zhu, W., Timmers, C. D., Raval, A., Tannehill‐Gregg, S. H., Morrison, C. D., Auer, H., Kratzke, R. A., Niehans, G. A., et al. (2004) · Oncogene · doi:10.1038/sj.onc.1207441 · Cited by 59
“In addition, fibronectin is upregulated during adenovirus E1A 12S mutant HBdl12-induced epithelial to mesenchymal transition in primary kidney cells (Kiemer et al., 2001).”
BackgroundSmith, K. T., Sardiu, M. E., Martin‐Brown, S., Seidel, C. W., Mushegian, A. R., Egidy, R., Florens, L. A., Washburn, M. P., & Workman, J. L. (2012) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m112.020255 · Cited by 58
“helps to bridge components of the extracellular matrix (44).”
BackgroundMyerburg, M. M., Latoche, J. D., McKenna, E. E., Stabile, L. P., Siegfried, J., Feghali‐Bostwick, C. A., & Pilewski, J. M. (2007) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00328.2006 · Cited by 60
“models (14, 52, 54, 55), and is believed to be involved in the pathogenesis of lung cancer (16), obliterative bronchiolitis (49), and idiopathic pulmonary fibrosis (52).”
BackgroundMontano, S. P., Coté, M. L., Fingerman, I., Pierce, M., Vershon, A. K., & Georgiadis, M. M. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.222312199 · Cited by 43
Tissue transglutaminase, inflammation, and cancer: how intimate is the relationship?
Kumar, S., & Mehta, K. (2011) · Amino Acids · doi:10.1007/s00726-011-1139-0 · Cited by 49
“For example, EMT has been implicated to play a role in wound healing, tissue regeneration, and organ fibrosis and initiate epithelial cancer cell invasion and metastasis (Kiemer et al. 2001; Janda et al. 2002; VincentSalomon and Thiery 2003).”
BackgroundDedifferentiated Adamantinoma With Revertant Mesenchymal Phenotype
Hazelbag, H. M., Laforga, J. B., Roels, H., & Hogendoorn, P. C. W. (2003) · The American Journal of Surgical Pathology · doi:10.1097/00000478-200312000-00005 · Cited by 42
Alwosaibai, K., Abedini, A., Al-Hujaily, E. M., Tang, Y., Garson, K., Collins, O. M., & Vanderhyden, B. C. (2017) · Oncotarget · doi:10.18632/oncotarget.20173 · Cited by 40
“While there is no evidence that OVE cells, SCOUTs or STICs undergo EMT, benign and malignant tumors are known to express EMT markers [28, 29].”
BackgroundRegulation of the C. elegans molt by pqn-47
Russel, S., Frand, A. R., & Ruvkun, G. (2011) · Developmental Biology · doi:10.1016/j.ydbio.2011.09.025 · Cited by 48
“It is expressed widely, including in brain, kidney, pancreas, uterus, testis, fetal heart and liver, respiratory, and other tissues (Berglund et al., 2008; Kiemer et al., 2001; Stohr et al., 2000).”
BackgroundBetulinic acid suppresses NGAL-induced epithelial-to-mesenchymal transition in melanoma
Gheorgheosu, D., Jung, M., Ören, B., Schmid, T., Dehelean, C. A., Muntean, D. M., & Brüne, B. (2013) · Biological Chemistry · doi:10.1515/hsz-2013-0106 · Cited by 39
Subramanian, M., Shan, J., Kühl, S. J., Tata, A., Pietilä, I., Kühl, M., & Vainio, S. J. (2012) · Experimental Cell Research · doi:10.1016/j.yexcr.2012.03.008 · Cited by 36
The Motile Breast Cancer Phenotype Roles of Proteoglycans/Glycosaminoglycans
Nikitovic, D., Kouvidi, K., Voudouri, K., Berdiaki, A., Karousou, E. G., Passi, A. G., & Tzanakakis, G. N. (2014) · BioMed Research International · doi:10.1155/2014/124321 · Cited by 40
“Indeed, the implication of matrix molecules contribution to EMT was evident even from early studies [87].”
BackgroundLü, S., Yu, G., Zhu, Y., & Archer, M. C. (2005) · International Journal of Cancer · doi:10.1002/ijc.21142 · Cited by 32
“undergoing epithelial to mesenchymal transition (EMT), a process that characterizes progression towards a malignant phenotype.(43,44)”
BackgroundProtein expression and promoter methylation of the candidate biomarker TCF21 in gastric cancer
Yang, Z., Li, D., Xie, Q., & Dai, D.-Q. (2014) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-014-1809-x · Cited by 31
“Malignant lesions are often defined by their differentiation status, where benign tumors typically retain their epithelial phenotype and malignant cells acquire a more fibroblastic mesenchymal phenotype (Kiemer et al. 2001).”
BackgroundXu, J., Li, D., Li, X., Liu, Z., Li, T., Jiang, P., He, Q., Tian, F., Gao, Y., Wang, D., et al. (2014) · Digestive and Liver Disease · doi:10.1016/j.dld.2014.03.017 · Cited by 29
Lysyl oxidases expression and histopathological changes of the diabetic rat nephron
Chen, J., Ren, J., Loo, W. T. Y., Hao, L., & Wang, M. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.8182 · Cited by 35
“Study from Kiemer et al also indicated that LOXL was upregulated in differentiated kidney epithelial cells undergoing the epithelial-mesenchymal transition, suggesting LOXL may have a role in remodeling the extracellular environment during dynamic processes such as tissue injury (20).”
Characterization of regulatory non-catalytic hexokinases in Aspergillus nidulans
Bernardo, S. M., Gray, K.-A., Todd, R. B., Cheetham, B. F., & Katz, M. E. (2007) · Molecular Genetics and Genomics · doi:10.1007/s00438-006-0203-z · Cited by 30
“If this is the case, the human homolog of XprG, C11orf9, which is upregulated in some tumour cells (Kiemer et al. 2001), may prove to have a role in apoptosis.”
BackgroundBorg, T. K. (2004) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63201-4 · Cited by 27
Cell Motility in Cancer Invasion and Metastasis
Qin, Z., Tan, S. X. D., & Cheng, C.-K. (2006) · Cancer metastasis · doi:10.1007/b103440 · Cited by 27
Pacheco-Domínguez, R. L., Palma‐Nicolás, J. P., López, E., & López-Colomé, A. M. (2007) · Experimental Eye Research · doi:10.1016/j.exer.2007.10.011 · Cited by 23
Yoo, S. B., Kim, Y. J., Kim, H., Jin, Y., Sun, P.-L., Jheon, S., Lee, J. S., & Chung, J.-H. (2013) · Annals of Surgical Oncology · doi:10.1245/s10434-013-2970-1 · Cited by 20
Involvement of epithelial-mesenchymal transition in adenoid cystic carcinoma metastasis
Sugiura, T. (2011) · International Journal of Oncology · doi:10.3892/ijo.2011.917 · Cited by 19
Molecular mechanisms of enzalutamide resistance in prostate cancer
Blatt, E. B., & Raj, G. V. (2019) · Cancer Drug Resistance · doi:10.20517/cdr.2019.25 · Cited by 26
“EPITHELIAL-MESENCHYMAL TRANSITION The epithelial-mesenchymal transition (EMT) is a process by which epithelial cells become more mesenchymal, a state characterized by increased invasive capacity, apoptotic resistance, and enhanced motility and metastatic potential([62-65]).”
Holliday, H., Roden, D. L., Junankar, S. R., Wu, S. Z., Baker, L. A., Krisp, C., Chan, C., McFarland, A., Skhinas, J. N., Cox, T. R., et al. (2021) · iScience · doi:10.1016/j.isci.2021.102072 · Cited by 32
Evasion of the Immune System by Adenoviruses
Blair, G. E., & Blair-Zajdel, M. E. (2004) · Current topics in microbiology and immunology · doi:10.1007/978-3-662-05599-1_1 · Cited by 18
O’Connell, K. M., Prencipe, M., O’Neill, A., Corcoran, C., Rani, S., Henry, M. A., Dowling, P., Meleady, P., O’Driscoll, L., Watson, R. W. G., et al. (2012) · PROTEOMICS · doi:10.1002/pmic.201100489 · Cited by 21
“EMT, the transition of cells from an epithelial to mesenchymal phenotype, occurs during cancer progression and can contribute to the migration and metastasis of cancer cells [39–41].”
BackgroundBijnsdorp, I. V., Schelfhorst, T., Luinenburg, M. J., Rolfs, F., Piersma, S. R., de Haas, R. R., Pham, T. V., & Jiménez, C. R. (2020) · Journal of Proteomics · doi:10.1016/j.jprot.2020.104076 · Cited by 14
Tetraspanin in oncogenic epithelial-mesenchymal transition
Muschel, R. J., & Gal, A. (2008) · Journal of Clinical Investigation · doi:10.1172/jci35308 · Cited by 12
In Vitro Matrices for Studying Tumor Cell Invasion
Yuan, K., Singh, R. K., Rezonzew, G., & Siegal, G. P. (2006) · Springer eBooks · doi:10.1007/1-4020-4009-1_2 · Cited by 10
López, E., Lee-Rivera, I., Álvarez-Arce, A., & López-Colomé, A. M. (2019) · Europe PMC (PubMed Central) · Cited by 8
Yu, X., Pan, X., Zhang, S., Zhang, Y., Chen, L., Wan, S., Huang, T., & Cai, Y. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2020.605012 · Cited by 10
Establishment and characterisation of two novel breast cancer cell lines
Bagadi, S. A. R., Kaur, J., & Ralhan, R. (2007) · Cell Biology International · doi:10.1016/j.cellbi.2007.08.010 · Cited by 7
“However, one of the cell lines, BCa-15, also showed expression of the mesenchymal cell marker, vimentin, suggesting partial transition of epithelial to mesenchymal cell type called metaplastic transition (Kiemer et al., 2001; Savagner, 2001).”
BackgroundMutant PIK3CA Induces EMT in a Cell Type Specific Manner
Bhagirath, D., Zhao, X., Mirza, S., West, W. W., Band, H., & Band, V. (2016) · PLoS ONE · doi:10.1371/journal.pone.0167064 · Cited by 7
Takeuchi, K., Sakurada, K., Endou, H., Obinata, M., & Quinlan, M. P. (2002) · Virology · doi:10.1006/viro.2002.1512 · Cited by 5
Self-citationBose, B., & Sudheer Shenoy, P. (2013) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24506 · Cited by 4
“Epithelial to mesenchymal transitions and vice versa are reported during many events in early embryogenesis [Hay, 1995] and carcinogenesis [Kierner et al., 2001].”
BackgroundTransporters in the Gastrointestinal Tract
Anderle, P., & Nielsen, C. U. (2008) · Methods and principles in medicinal chemistry · doi:10.1002/9783527623860.ch10 · Cited by 2
Evolutionary Origins of Metabolic Reprogramming in Cancer
García‐Sancha, N., Corchado‐Cobos, R., Gómez-Vecino, A., Jiménez‐Navas, A., Pérez‐Baena, M. J., Blanco‐Gómez, A., Holgado-Madruga, M., Mao, J., Cañueto, J., Castillo‐Lluva, S., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232012063 · Cited by 1
“This would also be the case for many genes linked to intermediate phenotypes shared by cancer and the wound-repair process [234].”
BackgroundProsdócimi, F. C. (2013) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.23.2013.tde-29052013-152333
Avaliação de marcadores relacionados à transição epitélio-mesênquima na endometriose pélvica
Poppe, A. C. M. (2013) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.5.2013.tde-20022014-092016
Passos, C. C. (2010) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.10.2010.tde-02022012-092917 · Cited by 5
Herbel, J. (2007) · Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver · doi:10.17169/refubium-13116
Holliday, H., Roden, D., Junankar, S., Wu, S. Z., Baker, L. A., Krisp, C., Chan, C.-L., McFarland, A., Skhinas, J. N., Cox, T. R., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.04.06.026963
Regulation of Phosphodiesterases by profibrotic reg ulators
Julia, E. S. (2008)
Jafari, S. M., & Gressner, O. A. (2009) · RWTH Publications (RWTH Aachen)
Rastegar‐Pouyani, N., Nasirpour, A., Jouni, F. J., Vazini, H., Moshaii, A., & Zafari, J. (2026) · Lasers in Medical Science · doi:10.1007/s10103-026-04825-4
“Some genes, like those studied in the present study, have been correlated with EMT [37].”
Rôle des protéines NLRP dans la physiopathologie des membranes foetales humaines.
Lavergne, M. (2019) · theses.fr (ABES) · doi:10.70675/cba6093az04b5z4414zb6a6z98dbbf90ced1
Metadata
- Authors
- Kiemer, A. K., Takeuchi, K., & Quinlan, M. P.
- Affiliations
- Ludwig-Maximilians-Universität München (DE)
- Corresponding author
- Quinlan, Margaret P
- ORCID
- Kiemer, Alexandra K
- Venue
- Oncogene
- Published
- 2001-10-11
- Volume
- 20
- Issue
- 46
- Pages
- 6679-6688
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2094157386
- Cited by
- 77
- References
- 69
- Citations by year
- 2026: 1 · 2022: 1 · 2021: 2 · 2020: 2 · 2019: 3 · 2018: 1 · 2017: 3 · 2016: 1 · 2014: 5 · 2013: 5 · 2012: 3
- FWCI
- 2.50
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Oncogene (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mechanisms of cancer metastasis
- Keywords
- epithelial-mesenchymal transition, tumor progression, dedifferentiation, metastasis, invasive tumors, differentially expressed genes, extracellular matrix genes, transcription factors, breast cancer, uterine cancer, lung cancer
- MeSH terms
- Adenoviridae, Cell Adhesion, Cell Line, Cytoskeleton, DNA, Epithelial Cells, Epithelium, Extracellular Matrix, Glycosylation, Humans, Mesoderm, Models, Biological, Nucleic Acid Hybridization, Protein Binding, Proteoglycans, RNA, Messenger, Up-Regulation, DNA, Complementary, Disease Progression, Reverse Transcriptase Polymerase Chain Reaction, Oligonucleotide Array Sequence Analysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.